Lutronic Changes the Game with the Derma V Dermatology Platform

Lutronic, the global leader in intelligent, energy-based systems for medical aesthetics, introduces Derma V, a ground-breaking dermatology workstation. Combining three unique treatment approaches – the core of a dermatologist’s toolbox – in one single, precise, powerful machine. Derma V has completely redefined the dermatology workstation. After years in the making, Lutronic has set an exceptional new standard for innovation and excellence with Derma V.

“We created a device that brings the essential lasers that skin specialists need for their daily work – vascular, pigment and rejuvenation – into a single, powerful and user-friendly technology,” states James Bartholomeusz, Lutronic’s Chief Technology Officer. “Lutronic improved every aspect of currently available platforms: usability, speed, safety, and tracking technology. This is the kind of leap in technological innovation that only happens every 15-20 years.”

Prior to Derma V, dermatologists and skin specialists were forced to juggle technologies, switching from one purpose-built laser to another to use the right tool for the right procedure, often sacrificing efficacy and safety for speed and useability, or vice-versa. A pulsed dye laser has long been the laser of choice for addressing various vascular issues but doesn’t target pigment concerns. While this laser may be safest and currently most efficacious, there are drawbacks to using it in a busy practice, such as breakdown-prone components and replaceable dyes that are less than ideal. This technology, in use across the industry, was long overdue for a complete reimagining.

Combining gold standard ICD skin cooling, optimal fluence, optimal wavelengths and flexible pulse duration and structures, the Derma V redefines what a 532nm “green” laser can be. The Derma V has over three times more power than the next best green laser, resulting in a wider range of fluence and spot size that help its more flexible wavelength penetrate deeper. It dramatically increases the range of possible treatments compared to green lasers of the past. Optimal cryogen based epidermal protection allows the operator to treat with the energy and power required for tough vascular lesions and to work quickly and efficiently, while providing comfort without pressure sensitivity or contact gels.

IntelliTrack™, Derma V’s proprietary, contact-based speed sensing technology, automatically tracks movement of the handpiece, delivering perfect coverage of the treatment area 3 times faster than any other solutions.

Dermatologists currently testing Derma V are enthusiastic. “I can precisely select the pulse wavelength and structure,” says Dr. Suzanne Kilmer, of Sacramento, CA. “Whether I’m targeting melanin, scars, or vessels of any size, I can pick and choose my ideal parameters. I’m effectively treating vascular lesions, as well as port wine stains that had not been responding as well to other laser treatments. I’m achieving safe and effective results with no side effects, and I can treat a large area much faster than I could with my old lasers.”

“Dermatologists need their technology – which they use all day, every day – to be as fast and reliable. They want multiple wavelengths and more power to be able to treat the widest array of pigment, vascular conditions,” Bartholomeusz explains. “But they also care about safety and keeping their patients comfortable. With Derma V, we created a workstation that brings the 532nm green laser together with the most powerful 1064nm laser to cover all the current treatment needs. These things, plus ICD cooling and IntelliTrack™, differentiate Lutronic’s state-of-the-art Derma V dermatology workstation from the rest, and set a new global standard for platform laser technology.”

 

SourceLUTRONIC

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”
Exit mobile version